Email Us
View Reports

Tetraphase Pharmaceuticals, Inc. Company Profile - Overview, History, SWOT Analysis, Products/Services, Facts, Financials, Key Executives, Competitors, Tech Intelligence, IT Outsourcing, IT Management, Recent Developments and Strategy Evaluation

  • ID : 6575798  |  
  • Published : Apr-2018  |  
  • Region : Global  |  
  • Pages : 37   |  
  • Publisher : Market Data Forecast

Tetraphase Pharmaceuticals (Tetraphase) is engaged in developing novel antibiotics for multidrug-resistant infections. The company primarily operates in the US and Bermuda.

The company's products pipeline comprises of eravacycline, TP-271 and TP-6076.

Eravacycline is a tetracycline derivative for the use as a first-line empiric mono-therapy for the treatment of multidrug-resistant infections, including multidrug-resistant gram-negative infections.

The company's TP-271 is a novel antibiotic, which is in phase I clinical trial development, developed to combat respiratory disease caused by bacterial bio-threats and antibiotic-resistant public health pathogens.

Tetraphase's TP-6076 (2nd generation gram-negative program) is involved in using proprietary chemistry technology to pursue the discovery and development of additional tetracycline-derived compounds effective against the most urgent multidrug-resistant gram-negative bacteria health threats.

The company's subsidiary are Tetraphase Securities Corporation, Tetraphase Pharma Securities, Inc. and Tetraphase Pharmaceuticals (Bermuda) Ltd.

Scope of the Report

-- About the Company - Historical Details, Current Ownership Structure and basic overview of Tetraphase Pharmaceuticals, Inc. in terms of revenue, net income, and operating income.

-- Financials - Details about Tetraphase Pharmaceuticals, Inc. listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.

-- Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.

-- Company SWOT Analysis - Outlines Tetraphase Pharmaceuticals, Inc.’s strengths, weaknesses, and opportunities and threats facing the company.

-- Recent Developments - Showcases Tetraphase Pharmaceuticals, Inc.’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.

-- Strategic Evaluation - Provides an overview of Tetraphase Pharmaceuticals, Inc.’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.

-- Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.

Key Questions Answered

-- What domain does Tetraphase Pharmaceuticals, Inc. operate and what are key points about it?

-- What is the product / service portfolio of Tetraphase Pharmaceuticals, Inc.?

-- How has Tetraphase Pharmaceuticals, Inc. performed financially from the 2013?

-- How does Tetraphase Pharmaceuticals, Inc. rank among its peers in terms of revenue and market share?

-- What are Tetraphase Pharmaceuticals, Inc. strengths and weaknesses and what opportunities and threats does it face?

-- What are Tetraphase Pharmaceuticals, Inc.’s main growth strategies and how successful has the company been at implementing them?

-- What is the in-house technical capability of Tetraphase Pharmaceuticals, Inc.? Where does it procure / outsource it?

Reasons to buy

-- Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own

-- Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost

-- 12 hour delivery time fulfilling your urgent requests as per your requirement

-- On-demand customization options that can completely cater to your needs by focusing the report onto given specifics

1. About the Company

1.1 History and Basic Facts

1.2 Ownership Structure and Key Executives

1.3 Head Office

1.4 Other Locations & Subsidiaries

1.5 List of Competitors

1.6 Employee Count & Distribution

2. Financials

2.1 Company Type (Listed / Unlisted)

2.2 Annual Statements

2.3 Key Financial Highlights

2.4 Region-wise Breakdown

3. Product / Services

3.1 Overview

3.2 Description

4. SWOT Analysis

4.1 SWOT Overview

4.2 Strengths

4.3 Weaknesses

4.4 Opportunities

4.5 Threats

5. Recent Developments

5.1 Mergers & Acquisitions

5.2 Partnerships, Collaborations & Joint Ventures

5.3 New Product Launches

5.4 Business Expansion / Divestment

6. Strategic Evaluation

6.1 Corporate Strategy

6.2 Legal Issues

6.3 Analyst Outlook

7. Technology Landscape

7.1 Industry

-- 7.1.1 Industry Snapshot

-- 7.1.2 IT Spend

-- 7.1.3 Key Information Technology Trends

7.2 Company

-- 7.2.1 IT Overview

-- 7.2.2 Key IT Technologies

-- 7.2.3 Recent IT Initiatives

-- 7.2.4 IT Outsourcing Engagements

-- 7.2.5 Key IT Management

-- 7.2.6 CIO/CTO Profile

Appendix

-- Methodology

-- About Us

-- Contact Us

-- Disclaimer

Fig.1: Company Snapshot

Fig.2: Locations Listing on Map

Table.1: Ownership Structure

Table.2: List of Competitors

Table.3: Annual Statements

Table.4: Key Financial Highlights

Table.5: Region-wise Breakdown

Table.6: Product/Services Overview

Table.7: Mergers & Acquisitions

Table.8: Partnerships, Collaborations & Joint Ventures

Table.9: New Product Launches

Table.10: Business Expansion / Divestment

Table 11: IT Budgets

Table 12: Key IT Management (CIO / CTO)

Table 13: IT Deals undertaken in the past years

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?